Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:55 PM
Ignite Modification Date: 2025-12-24 @ 9:55 PM
NCT ID: NCT02945332
Eligibility Criteria: Inclusion Criteria: 1. Sedentary (\< 3 hours/week of moderate intensity physical activity), and otherwise healthy men and women 2. Willingness to: follow the instructions, and to attend regularly, 3. BMI 25 - 50 kg/M2 4. Age: 18y - 65 y. Subjects will be screened prior to the study. Exclusion Criteria: 1. Significant cardiac disease in the past 6 months (Myocardial Infarction, angioplasty, Congestive Heart Failure, Left Bundle Branch Block, 3rd degree AV- block, CABG), 2. Uncontrolled hypertension (systolic BP \> 180 or diastolic BP \> 105 mm Hg), 3. Medications that could interfere with outcomes and that could not be safely withdrawn prior to testing, 4. Pregnancy or intention to conceive during the study period, 5. Current substance abuse, 6. Indications of potential difficulties adhering to the protocol, 7. Subjects who in the opinion of the investigators are inappropriate for study participation or who would be at additional risk by participating, 8. Physical or medical limitation for exercise, intermittent claudication, severe back pain or spasm, inability to ambulate independently or without the use of a cane or walker, 9. Unexcused absence for more than 2 continuous weeks, irregular attendance, non-cooperation, conception, or change in the health status that would jeopardize the subject could be grounds for expulsion from the study.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT02945332
Study Brief:
Protocol Section: NCT02945332